Introduction: Systemic inflammation has been shown to significantly worsen the outcome of neurological disease. However, after acute injuries to the brain both pre- and post-conditioning with bacterial endotoxin has been shown to reduce leukocyte recruitment to the CNS. Here, we sought to determine whether viral pre-challenge would have an effect on the outcome of acute CNS inflammation that was distinct from endotoxin.

Methods: Animals received a single intracranial microinjection of IL-1β in the presence or absence of a viral pre-challenge 24 hours prior to surgery. Liver and brain tissue were analysed for chemokine expression by qRT-PCR and leukocyte and monocyte infiltration 12 hours, 3 days and 7 days after the IL-1β injection.

Results: Here, a single injection of adenovirus prior to IL-1β injection resulted in adhesion molecule expression, chemokine expression and the recruitment of neutrophils to the injured CNS in significantly higher numbers than in IL-1β injected animals. The distribution and persistence of leukocytes within the CNS was also greater after pre-challenge, with neutrophils being found in both the ipsilateral and contralateral hemispheres. Thus, despite the absence of virus within the CNS, the presence of virus within the periphery was sufficient to exacerbate CNS disease.

Conclusions: These data suggest that the effect of a peripheral inflammatory challenge on the outcome of CNS injury or disease is not generic and will be highly dependent on the nature of the pathogen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201684PMC
http://dx.doi.org/10.1186/s12974-014-0178-3DOI Listing

Publication Analysis

Top Keywords

viral pre-challenge
12
chemokine expression
8
cns
7
pre-challenge increases
4
increases central
4
central nervous
4
nervous system
4
system inflammation
4
inflammation intracranial
4
intracranial interleukin-1β
4

Similar Publications

Article Synopsis
  • Rhesus macaques vaccinated with RhCMV/SIV show about 59% protection against SIVmac239M exposure, but the mechanism behind this protection is still unclear.
  • Researchers explored how the gut microbiome of the macaques influences the effectiveness of the vaccine, analyzing rectal swabs for microbial profiles before and after SIV exposure.
  • They discovered a common gut microbial signature associated with vaccine protection across different vaccination groups, indicating that gut microbiota play a significant role in the immune response to the RhCMV/SIV vaccine.
View Article and Find Full Text PDF

Vaccination against influenza virus can reduce the risk of influenza by 40% to 60%, they rely on the production of neutralizing antibodies specific to influenza hemagglutinin (HA) ignoring the neuraminidase (NA) as an important surface target. Vaccination with standardized NA concentration may offer broader and longer-lasting protection against influenza infection. In this regard, we aimed to compare the potency of a NA displayed on the surface of a VLP with a soluble NA.

View Article and Find Full Text PDF

Background: Dengue human infection models (DHIMs) are important tools to down-select dengue vaccine candidates and establish tetravalent efficacy before advanced clinical field trials. We aimed to provide data for the safety and immunogenicity of DHIM and evaluate dengue vaccine efficacy.

Methods: We performed an open-label, phase 1 trial at the University of Maryland (Baltimore, MD, USA).

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2, which emerged in late 2019, has caused a global pandemic, with 34 vaccines approved and about 67% of the world vaccinated, yet new infections and variants still pose challenges.
  • Researchers evaluated a new measles virus-vectored vaccine (V591) designed to target the SARS-CoV-2 spike protein in an African green monkey model, demonstrating strong immune responses pre-challenge.
  • V591-vaccinated monkeys showed reduced viral loads and earlier cessation of virus shedding after exposure to SARS-CoV-2, leading to a lower disease burden in their lungs compared to those given a control vaccine.
View Article and Find Full Text PDF

Cardiomyopathy syndrome (CMS) caused by piscine myocarditis virus (PMCV) is a severe cardiac disease in Atlantic salmon (Salmo salar) and one of the leading causes of morbidity and mortality in the Norwegian aquaculture industry. Previous research suggest a variation in individual susceptibility to develop severe disease, however the role of the immune response in determining individual outcome of CMS is poorly understood particularly in cases where fish are also challenged by stress. The present study's aim was therefore to characterize cardiac transcriptional responses to PMCV infection in Atlantic salmon responding to infection under stressful conditions with a high versus low degree of histopathological damage.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!